Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca

[ad_1] Aykut Karahan | Istock | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Happy Friday! Buried in the election news this week was new data from drugmakers vying to enter the booming … Read more

Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity

[ad_1] The “Wegovy” brand slimming syringe is sold in the Achat pharmacy in Mitte. The “Wegovy” slimming syringe has been available in Germany for a year. Jens Kalaene | Picture Alliance | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your … Read more

Op-ed: The financial toxicity of cancer is growing. Here’s what can be done to reduce it

[ad_1] Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture Alliance | Getty Images Cancer drains individuals of their physical, emotional, and financial health. Given the impact on both patients and the people in their lives — including their employer — it’s time that CEOs … Read more

Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034

[ad_1] A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk.  Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Good afternoon and … Read more

Healthy Returns: What activist Starboard’s $1 billion stake means for Pfizer

[ad_1] Jakub Porzycki | Nurphoto | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Happy Tuesday! Pfizer‘s troubles may finally be coming to a head.  Former executives of the pharmaceutical giant are backing … Read more

Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters

[ad_1] Kena Betancur | Corbis News | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Hello and happy Tuesday! Today, we’re unpacking a shocking move from Pfizer.  The pharmaceutical giant last week announced … Read more

Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next

    Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Good … Read more

Healthy Returns: How competitive can Roche be in the weight loss drug market?

[ad_1] Headquarters of Roche, multinational pharmaceutical industry on December 27, 2021 in Madrid, Spain.  Cristina Arias | Cover | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Good afternoon! Roche is one of several … Read more

Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs

[ad_1] Weight loss syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Picture Alliance | Picture Alliance | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive … Read more

Healthy Returns: What to know about the latest round of Pfizer, Moderna Covid vaccines

[ad_1] Moderna Covid-19 Vaccine mRNA 2024-2025 formula. Courtesy: Moderna A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. It’s that time of the year again. A new round of Covid shots is on its way to … Read more